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ABSTRACT: The catalytic asymmetric synthesis of alkyl
ﬂuorides, particularly α-ﬂuorocarbonyl compounds, has
been the focus of substantial eﬀort in recent years. While
signiﬁcant progress has been described in the formation of
enantioenriched secondary alkyl ﬂuorides, advances in the
generation of tertiary alkyl ﬂuorides have been more
limited. Here, we describe a method for the catalytic
asymmetric coupling of aryl alkyl ketenes with commer-
cially available N-ﬂuorodibenzenesulfonimide (NFSI) and
C6F5ONa to furnish tertiary α-ﬂuoroesters. Mechanistic
studies are consistent with the hypothesis that the addition
of an external nucleophile (C6F5ONa) is critical for
turnover, releasing the catalyst (PPY*) from an N-acylated
intermediate. The available data can be explained by a
reaction pathway wherein the enantioselectivity is
determined in the turnover-limiting transfer of ﬂuorine
from NFSI to a chiral enolate derived from the addition of
PPY* to the ketene. The structure and the reactivity of the
product of this proposed elementary step, an α-ﬂuoro-N-
acylpyridinium salt, have been examined.
Because of properties such as the high electronegativity andthe small size of ﬂuorine, as well as the relative stability of
the C−F bond, the incorporation of ﬂuorine into organic
molecules, including stereoselective processes, has become a
widely used method in medicinal chemistry for altering the
bioactivity of drug candidates.1 The catalytic enantioselective α-
ﬂuorination of carbonyl compounds has been a subject of
particular interest,2 and an array of versatile methods have been
described for the generation of such secondary alkyl ﬂuorides.3,4
In contrast, except in the case of doubly activated molecules,2,5
there has been limited progress in the development of eﬀective
processes that furnish tertiary α-ﬂuorocarbonyl compounds,6−8
and we are not aware of any methods that directly aﬀord esters,9
with the exception of kinetic resolutions.10 Here, we establish
that a planar-chiral nucleophilic catalyst (PPY*) can achieve the
coupling of a ketene,11 an electrophilic ﬂuorine source,12 and an
alkoxide, thereby providing such tertiary alkyl ﬂuorides with high
enantioselectivity (eq 1). We also present mechanistic studies
that help to illuminate the reaction pathway.
In an earlier study, we reported that PPY* can catalyze the
asymmetric chlorination of ketenes by 2,2,6,6-tetrachlorocyclo-
hexanone to produce tertiary α-chloroesters.13 When we
attempted to extend this halogenation strategy to an analogous
enantioselective ﬂuorination of ketenes, building in part on the
pioneering work of Lectka on the cinchona alkaloid/palladium/
LiClO4-catalyzed synthesis of secondary alkyl ﬂuorides from acid
chlorides and N-ﬂuorodibenzenesulfonimide (NFSI; commer-
cially available),4 we obtained discouraging results (eq 2).
We postulated that our failure to achieve the desired catalytic
asymmetric ﬂuorination might be due to the stability of a
potential N-acylpyridinium intermediate (e.g., 1) toward
(SO2Ph)2N
−. Consequently, we decided to determine if the
addition to the reaction mixture of a stoichiometric quantity of a
more reactive nucleophile might be beneﬁcial. We were, of
course, cognizant of the possibility that the nucleophilic additive
might react directly with the ketene to generate an achiral enolate
and racemic product; fortunately, however, we were able to
identify a nucleophile that allowed us to achieve our objective
(Table 1).
Whereas the addition of MeOH or PhNH2 did not result in a
signiﬁcant amount of the desired tertiary alkyl ﬂuoride (Table 1,
entries 1 and 2), the use of alkoxides led to a substantial quantity
(entries 3−5). In the case of sodium tert-butoxide, the product
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was racemic (entry 3); on the other hand, sodium phenoxide
furnished good enantioselectivity (entry 4), and a less
nucleophilic phenoxide, sodium pentaﬂuorophenoxide, provided
excellent yield and ee (entry 5).14
Our optimized method is eﬀective for the catalytic
enantioselective synthesis of tertiary α-ﬂuoroesters from an
array of aryl alkyl ketenes (Table 2).15 The alkyl group of the
ketene can vary in size from Me to cyclopentyl (entries 1−5;
lower ee is observed with larger alkyl groups), and the aromatic
substituent can be electron-poor, electron-rich, para-substituted,
or meta-substituted (entries 6−9), as well as naphthyl or
heteroaryl (entries 10 and 11). On a gram scale, the ﬂuorination
illustrated in entry 2 of Table 2 proceeded in 99% ee and 90%
yield.
Although our other chiral 4-(dimethylamino)pyridine
(DMAP)-catalyzed reactions of ketenes have generally not
been eﬀective for dialkyl ketenes,16 in the case of this asymmetric
ﬂuorination process, we have observed a promising level of
enantioselectivity (eq 3).
The enantioenriched α-ﬂuoroesters that are generated in this
catalytic asymmetric C−F bond-forming process can be
transformed in good yield into a variety of other tertiary alkyl
ﬂuorides (Figure 1).
Two of the possible pathways for the PPY*-catalyzed
enantioselective ﬂuorination of ketenes to generate enantioen-
riched tertiary α-ﬂuoroesters are illustrated in Figure 2. In one
mechanism, a PPY*-derived chiral enolate (2) is a key
intermediate (top), and in the other a PPY*-derived chiral
ﬂuorinating agent (4) is critical (bottom).17 To gain insight into
the operative pathway, we determined the rate law for the
reaction of phenyl ethyl ketene, which is ﬁrst order in PPY* and
in NFSI, and zeroth order in the ketene and in C6F5ONa.
18 The
rate of product formation does vary with the identity of the
ketene, suggesting that the ketene is involved in the rate-
determining step.
These observations are consistent with a “chiral enolate”
pathway (top of Figure 2; but not with a “chiral ﬂuorinating
Table 1. Catalytic Asymmetric Synthesis of Tertiary Alkyl
Fluorides: Eﬀect of Added Nucleophilea
aAll data are the averages of two experiments. bDetermined through
GC analysis with the aid of an internal standard. cYield of puriﬁed
product.
Table 2. Catalytic Asymmetric Synthesis of Tertiary Alkyl
Fluoridesa
aFor the reaction conditions, see eq 1. All data are the averages of two
experiments. bYield of puriﬁed product (contains ≤5% of the non-
ﬂuorinated ester). cCatalyst loading: 10%.
Figure 1. Transformations of an enantioenriched tertiary α-ﬂuoroester.
Figure 2. An outline of two of the possible mechanisms for the PPY*-
catalyzed enantioselective α-ﬂuorination of ketenes: a “chiral enolate”
pathway (top) and a “chiral ﬂuorinating agent” pathway (bottom).
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agent” pathway (bottom of Figure 2)19) wherein nucleophilic
addition of PPY* to the ketene aﬀords enolate 2, this enolate is
the resting state of the catalytic cycle,20 and, in the turnover-
limiting step, enolate 2 is ﬂuorinated by NFSI to provide
enantioenriched N-acylpyridinium salt 3. Reaction with the
phenoxide then furnishes the tertiary α-ﬂuoroester and
regenerates the catalyst, PPY*.
In view of our earlier inability to achieve PPY*-catalyzed
asymmetric ﬂuorination of ketenes with NFSI in the absence of
an added nucleophile (eq 2), we hypothesized that N-
acylpyridinium salt 3 (Figure 2) might be isolable. Indeed,
reaction of PPY*, phenyl benzyl ketene, and NFSI (1:1:1)
provided α-ﬂuorinated acylpyridinium salt 5 (eq 4).21,22 This ion
pair is stable at room temperature under nitrogen for at least 6
months.
Although we were not able to obtain X-ray-quality crystals of
the sulfonimide salt of theN-acylpyridinium ion, anion exchange
of N(SO2Ph)2 for a carborane through treatment with
CsCB11H12 furnished a suitable crystal (Figure 3).
23 The
pyrrolidino group, the pyridine ring, and the carbonyl group
are approximately coplanar, consistent with extended con-
jugation of the π system, which decreases the electrophilicity of
the carbonyl group. With regard to the orientation around the
N−Ccarbonyl bond, the smaller group (carbonyl oxygen) is
positioned on the side of the fused cyclopentadienyl ring,
presumably to minimize unfavorable steric interactions. The
stereochemistry of the ﬂuorine-bearing carbon of the N-
acylpyridinium ion is the same as for the major enantiomer of
the α-ﬂuoroester that is generated by (+)-PPY* under our
standard ﬂuorination conditions.
We have conﬁrmed thatN-acylpyridinium salt 5 is a chemically
and kinetically competent potential intermediate in the proposed
catalytic cycle that leads to the enantioenriched tertiary α-
ﬂuoroester (top of Figure 2). Thus, upon treatment of this salt
with C6F5ONa in THF at −78 °C, the enantioenriched ester is
formed with retention of stereochemistry (eq 5). It is interesting
to note that this catalyst-regeneration issue from an N-acylated
catalyst intermediate is not encountered in “related” processes
such as the PPY*-catalyzed α-chlorination of ketenes13 or the
cinchona alkaloid-catalyzed α-ﬂuorination of acid chlorides (via
monosubstituted ketenes) to aﬀord secondary α-ﬂuoroesters.4
In conclusion, we have described a method for the catalytic
enantioselective coupling of aryl alkyl ketenes (and a dialkyl
ketene) with NFSI and C6F5ONa to produce tertiary α-
ﬂuoroesters, a family of target molecules that have rarely been
directly accessed via asymmetric catalysis. The addition of
C6F5ONa was critical to the success of this eﬀort, as it enables
regeneration of the catalyst (PPY*) from a relatively stable N-
acylated intermediate, which we have synthesized and inves-
tigated independently. Our mechanistic studies are consistent
with a catalytic cycle wherein PPY* adds to the ketene and
generates a chiral enolate which, in the stereochemistry- and rate-
determining step, reacts with NFSI to furnish the enantioen-
riched N-acylpyridinium salt.
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